Researchers in Japan have demonstrated that the formation of cell membrane pores is a major mechanism by which cancer-inducing proteins are released and hasten tumor development in nonalcoholic steatohepatitis (NASH)-associated liver cancer.

Cases of NASH—a type of fatty liver disease that may lead to cancer—are on the rise, and effective treatments have been elusive. But a recent study in the journal Science Immunology describes how work led by Osaka Metropolitan University may be a potential step toward suppression and treatment of such cancers.

Using obese mice, the research team demonstrates the importance of secreted proteins that are secreted from cell membrane pores formed near cancer cells in the tumor microenvironment. 

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

While cancer cells themselves are obviously detrimental, neighboring cells including cancer-associated fibroblasts in the tumor microenvironment can play a part in cancer development. “In the obesity-associated liver tumor microenvironment, the fibroblasts called ‘hepatic stellate cells’ become senescent,” says lead researcher Professor Naoko Ohtani. “This causes them to exhibit a senescence-associated secretory phenotype (SASP), where they release a set of proteins that promote cancer by suppressing anti-tumor immunity.”

The mechanism by which proteins such as SASP factors are released and accelerate tumor development remains unclear. But Professor Ohtani’s team attempted to uncover this mechanism by feeding a high-fat diet to cancer-prone mice and studying the obesity-induced liver cancer. They first conducted gene expression analysis to determine what SASP factors were produced by hepatic stellate cells and then investigated how they were released.

The SASP factors IL-1β and IL-33 were discovered to be two of the key facilitators of liver cancer growth. Their release occurs in two main stages. “First, the high-fat diet weakens gut barrier function, resulting in the migration and accumulation of lipoteichoic acid in the liver,” Professor Ohtani elaborated. “Second, the accumulated lipoteichoic acid stimulates the cleavage of gasdermin D protein. This, in turn, forms cell membrane pores where IL-1β and IL-33 are exported or released from hepatic stellate cells.”

These pores play a crucial role, because once IL-33 is released, it activates its receptor-positive regulatory T cells that act to suppress the immune response to cancer cells and potentially exacerbate cancer development.

Understanding this mechanism is an important advance in humanity’s battle against cancer. “Our study revealed a very interesting mechanism by which the tumor-promoting SASP factors are released through the cell membrane pores formed by the stimulation of gut microbial component,” adds Professor Ohtani. “Inhibiting this pore formation may facilitate prevention and therapeutic strategies for NASH-associated liver cancer patients.”